SI
MRNS

Sofinnova Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Sofinnova Investments’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,386,177
Closed -$7.72M – 79
2024
Q3 		$7.72M Buy
4,386,177
+234,601
+6% +$327K 0.64% 36
2024
Q2 		$4.86M Buy
4,151,576
+2,750,523
+196% +$6.88M 0.31% 56
2024
Q1 		$12.7M Sell
1,401,053
-371,646
-21% -$3.61M 0.75% 34
2023
Q4 		$19.3M Buy
1,772,699
+787,093
+80% +$5.9M 1.08% 22
2023
Q3 		$7.93M Buy
985,606
+22,987
+2% +$191K 0.55% 40
2023
Q2 		$10.5M Sell
962,619
-237,770
-20% -$2.04M 0.69% 31
2023
Q1 		$8.28M Buy
+1,200,389
New +$7.53M 0.56% 34
2022
Q1 		– Sell
-171,338
Closed -$2.04M – 88
2021
Q4 		$2.04M Buy
171,338
+4,627
+3% +$53.4K 0.13% 63
2021
Q3 		$1.9M Sell
166,711
-179,449
-52% -$2.47M 0.12% 66
2021
Q2 		$6.21M Sell
346,160
-24,191
-7% -$389K 0.38% 45
2021
Q1 		$5.73M Buy
370,351
+96,324
+35% +$1.39M 0.36% 47
2020
Q4 		$3.34M Buy
+274,027
New +$3.82M 0.21% 56
2020
Q3 		– Hold
0
– – – 99

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return